No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer

J Clin Oncol. 2019 Oct 10;37(29):2707-2708. doi: 10.1200/JCO.19.01650. Epub 2019 Aug 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bevacizumab
  • Carcinoma, Ovarian Epithelial*
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial*
  • Ovarian Neoplasms*

Substances

  • Bevacizumab